DESIGN OF THE SILENT CEREBRAL INFARCT TRANSFUSION (SIT) TRIAL

BACKGROUND: Silent cerebral infarct (SCI) is the most common cause of serious neurological disease in sickle cell anemia (SCA), affecting approximately 22% of children. The goal of this trial is to determine whether blood transfusion therapy will reduce further neurological morbidity in children wit...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pediatr Hematol Oncol
Glavni autori: Casella, James F., King, Allison A., Barton, Bruce, White, Desiree A., Noetzel, Michael J., Ichord, Rebecca N., Terrill, Cindy, Hirtz, Deborah, McKinstry, Robert C., Strouse, John J., Howard, Thomas H., Coates, Thomas D., Minniti, Caterina P, Campbell, Andrew D., Vendt, Bruce A., Lehmann, Harold, DeBaun, Michael R.
Format: Artigo
Jezik:Inglês
Izdano: 2010
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572477/
https://ncbi.nlm.nih.gov/pubmed/20201689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/08880010903360367
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items